PRKCB and neoplasm: For example, the interaction between ZMYND8 and PKCβ or TROJAN may induce pro-oncogenic effects, while interaction between ZMYND8 and KDM5C, KDM5D, or ZNF592 may cause tumor-suppressive effects.